Chandrashekar P - Search Results

1

Comparative Outcomes of a Transthyretin Amyloid Cardiomyopathy Cohort Versus Patients With Heart Failure With Preserved Ejection Fraction Enrolled in the TOPCAT Trial.

Kim MM, Prasad M, Burton Y, Kolseth CM, Zhao Y, Chandrashekar P, Nazer B, Masri A. Kim MM, et al. Among authors: chandrashekar p. J Am Heart Assoc. 2023 Aug;12(15):e029705. doi: 10.1161/JAHA.123.029705. Epub 2023 Jul 31. J Am Heart Assoc. 2023. PMID: 37522238 Free PMC article.

2

Hearts and bones: choose your tracers wisely.

Chandrashekar P, Al-Rashdan L, Dale Z, Masri A. Chandrashekar P, et al. Eur Heart J. 2020 Dec 14;41(47):4524. doi: 10.1093/eurheartj/ehaa653. Eur Heart J. 2020. PMID: 32789439 No abstract available.

3

Incidental extra-cardiac uptake of ^99mTc-pyrophosphate.

Chandrashekar P, Masri A. Chandrashekar P, et al. J Nucl Cardiol. 2022 Oct;29(5):2721-2723. doi: 10.1007/s12350-020-02498-2. Epub 2021 Jan 6. J Nucl Cardiol. 2022. PMID: 33409892 No abstract available.

4

Management Strategies for Atrial Fibrillation and Flutter in Patients with Transthyretin Cardiac Amyloidosis.

Dale Z, Chandrashekar P, Al-Rashdan L, Kim M, Masri A, Nazer B. Dale Z, et al. Among authors: chandrashekar p. Am J Cardiol. 2021 Oct 15;157:107-114. doi: 10.1016/j.amjcard.2021.07.028. Epub 2021 Aug 6. Am J Cardiol. 2021. PMID: 34366115

5

Prevalence and Outcomes of p.Val142Ile TTR Amyloidosis Cardiomyopathy: A Systematic Review.

Chandrashekar P, Alhuneafat L, Mannello M, Al-Rashdan L, Kim MM, Dungu J, Alexander K, Masri A. Chandrashekar P, et al. Circ Genom Precis Med. 2021 Oct;14(5):e003356. doi: 10.1161/CIRCGEN.121.003356. Epub 2021 Aug 31. Circ Genom Precis Med. 2021. PMID: 34461737 Free PMC article.

6

Targeted treatments of AL and ATTR amyloidosis.

Chandrashekar P, Desai AK, Trachtenberg BH. Chandrashekar P, et al. Heart Fail Rev. 2022 Sep;27(5):1587-1603. doi: 10.1007/s10741-021-10180-z. Epub 2021 Nov 16. Heart Fail Rev. 2022. PMID: 34783948 Review.

7

Mode of death and outcomes of implantable cardioverter defibrillators in transthyretin amyloid cardiomyopathy.

Dale Z, Al-Rashdan L, Elman M, Chandrashekar P, Heitner SB, Nazer B, Masri A. Dale Z, et al. Among authors: chandrashekar p. Int J Cardiol. 2022 Feb 15;349:99-102. doi: 10.1016/j.ijcard.2021.11.057. Epub 2021 Nov 27. Int J Cardiol. 2022. PMID: 34843821

8

Navigating the Complex Web of Prescribing Amyloidosis Therapeutics: A Primer.

Chen H, Chandrashekar P, Fischer K, Carlson D, Narayan U, Chen J, Masri A. Chen H, et al. Among authors: chandrashekar p. J Am Heart Assoc. 2022 Apr 5;11(7):e023895. doi: 10.1161/JAHA.121.023895. Epub 2022 Mar 18. J Am Heart Assoc. 2022. PMID: 35301856 Free PMC article. Review.

9

Routine ambulatory heart rhythm monitoring for detection of atrial arrhythmias in transthyretin cardiac amyloidosis.

Dale Z, Chandrashekar P, Al-Rashdan L, Gill S, Elman M, Fischer KL, Nazer B, Masri A. Dale Z, et al. Among authors: chandrashekar p. Int J Cardiol. 2022 Jul 1;358:65-71. doi: 10.1016/j.ijcard.2022.04.045. Epub 2022 Apr 18. Int J Cardiol. 2022. PMID: 35439584

10

Evolving epidemiology of transthyretin amyloid cardiomyopathy due to increased recognition in women.

Prasad M, Kim M, Chandrashekar P, Zhao Y, Fischer KL, Nazer B, Masri A. Prasad M, et al. Among authors: chandrashekar p. Int J Cardiol. 2023 Mar 1;374:116-119. doi: 10.1016/j.ijcard.2022.12.048. Epub 2022 Dec 29. Int J Cardiol. 2023. PMID: 36587655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters